V.D. ZAKHAROV, D.O. SHKVORCHENKO, E.A. KRUPINA, V.A. PISMENSKAYA, S.A. KAKUNINA, K.S. NORMAN

Interbranch Scientific and Technical Complex «Eye Microsurgery» named after acad. S.N. Fedorov, 59a Beskudnikovsky Blvd., Moscow, Russian Federation, 127474

 Zakharov V.D. ― D. Med. Sc., Professor, Head of the Department of Vitreoretinal Surgery, tel. (499) 488-87-17, e-mail: info@mntk.ru

Shkvorchenko D.O. ― Cand. Med. Sc., Deputy Chief Doctor on Medical Work, tel. (499) 488-84-29, e-mail: info@mntk.ru

Krupina E.A. ― postgraduate student, tel. +7-916-427-16-65, e-mail: ew.krupina@yandex.ru

Pismenskaya V.A. ― employee of the Department of Clinical-Functional Diagnostics, tel. (499) 488-72-11, e-mail: info@mntk.ru

Kakunina S.A. ― Cand. Med. Sc., Researcher of the Department of Vitreoretinal Surgery, tel. (499) 488-87-17, e-mail: info@mntk.ru

Norman K.S. ― Cand. Med. Sc., Researcher of the Department of Vitreoretinal Surgery, tel. (499) 488-87-17, e-mail: info@mntk.ru

 The article describes a study of 14 patients operated for large macular raptures. During surgery, after the vitrectomy, internal limiting membrane removing and air tampons, the platelet-rich plasma was introduced in the region of the rapture without mechanical edge closing. The observation period was 3 months. Anatomical closure was confirmed in all cases, the visual acuity increased to 0.7. This new technique of macular rapture surgical treatment with platelet-rich plasma is associated with better anatomical and functional results.

Key words: macular rapture, platelet-rich plasma, internal limiting membrane, vitrectomy, vitreo-macular interface.

REFERENCES

1. Alpatov S.A., Shchuko A.G., Malyshev V.V. Patogenez i lechenie idiopaticheskikh makulyarnykh razryvov [Pathogenesis and treatment of idiopathic macular ruptures]. Novosibirsk: Nauka, 2005. 192 p.
2. Shkvorchenko D.O., Khoroshilova-Maslova I.P., Andreeva L.D. et al. Khirurgicheskoe lechenie idiopaticheskikh razryvov s udaleniem vnutrenney pogranichnoy membrany setchatki [Surgical treatment of idiopathic ruptures with the removal of the internal border membrane of the retina]. Sovremennye tekhnologii lecheniya vitreoretinal’noy patologii: Sb. nauch. st. Moscow, 2002. Pp. 338-346.
3. Gupta D. Face-down posturing after macular hole surgery. A review. Retina, 2009, vol. 29, no. 4, pp. 430-443.
4. Jančo L., Vida R., Bartoš M. et al. Surgical treatment of the idiopatic macular hole — our experience. Cesk Slov Oftalmol, 2013, vol. 69, no. 3, pp. 102-105.
5. Belyy Yu.A., Tereshchenko A.V., Shkvorchenko D.O. et al. Surgical treatment of large idiopathic macular ruptures. Prakticheskaya meditsina, 2015, no. 2, pp. 119-123 (in Russ.).
6. Stolyarenko G.E., Savost’yanova N.V., Levkovets V.E. How can we simultaneously fight for a functional result and think about the way out of a possible confusion in the primary surgery of the through-hole macular hole. Mir oftal’mologii, 2016, no. 3 (29), pp. 4-5 (in Russ.).
7. Duker J.S., Kaiser P.K., Binder S. et al. The Internation Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology, 2013, vol. 120, no. 12, pp. 2611-2619.
8. Michalewska Z., Michalewski J., Adelman R. et al. Inverted internal limiting membrane flap technique for large macularholes. Ophthalmology, 2010, vol. 117, no. 10, pp. 2018-2025.
9. Michalewska Z., Michalewski J., Dulczewska-Cichecka K. et al. Inverted internal limiting membrane flap technique for surgical repair of myopic macular holes. Retina, 2014, vol. 34, no. 4, pp. 664-669.
10. Kelly N.E., Wendel R.T. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch. Ophthalmolog, 1991, vol. 109, pp. 654-659.
11. Gaudric A., Massin P., Paques M., et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch. Clin. Exp. Ophthalmol, 1995, vol. 233, no. 9, rr. 549-554.
12. Korobelnik J.F., Hannouche D., Belayachi N. et al. Autologous platelet concentrate as an adjunct in macular hole healing: a pilot study. Ophthalmology, 1996, vol. 103, no. 4, rr. 590-594.
13. Velhagen K.H., Druegg A., Rieck R. Rroliferation and wound healing of retinal pigment epithelium cells in vitro. Effect of human thrombocyte concentrate, serum and PDGF. Ophthalmologe, 1999, vol. 96, no. 2, rr. 77-81.
14. García-Arumí J., Martinez V., Puig J. et al. The role of vitreoretinal surgery in the management of myopic macular hole without retinal detachment. Retina, 2001, vol. 21, no. 4, rr. 332-338.
15. Konstantinidis A., Hero M., Nanos P., et al. Efficacy of autologous platelets in macular hole surgery. Clin. Ophthalmol, 2013, vol. 7, rr. 745.
16. Cheung C.M.G., Munshi V., Mughal S., et al. Anatomical success rate of macular hole surgery with autologous platelet without internal-limiting membrane peeling. Eye, 2005, vol. 19, no. 11, rr. 1191-1193.
17. Kube T., Hermel M., Dahlke C. et al. Macular hole surgery: experience with autologous platelet concentrate and indocyanine green-assisted internal limiting membrane peeling. Klin. Monbl. Augenheilkd, 2002, vol. 219, no. 12, rr. 883-888.
18. Mulhern M.G., Cullinane A., Cleary P.E. Visual and anatomical success with short-term macular tamponade and autologous platelet concentrate. Graefes Arch. Clin. Exp. Ophthalmol, 2000, vol. 238, no. 7, rr. 577-583.
19. Paques M., Chastang C., Mathis A, et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology, 1999, vol. 106, no. 5, rr. 932-938.
20. Shpak A.A., Ogorodnikova S.N. Epiretinal membranes in patients with unilateral idiopathic macular ruptures. Vestnik oftal’mologii, 2009, no. 4, pp. 18-21 (in Russ.).
21. Inoue M., Morita S., Watanabe Y. et al. Preoperative inner segment/outer segment junction in spectral domain opticalcoherent tomography as a prognostic factor in epiretinal membrane surgery. Retina, 2011, vol. 31, no. 7, pp. 1366-1372.
22. Kalmykova N.V., Skorobogataya E.V., Berestovoy M.A. et al. Comparative characteristics of thrombocyte lysates from different donors. Kletochnye tekhnologii v biologii i meditsine, 2011, no. 2, pp. 114-117 (in Russ.).
23. Achkasov E.E., Bezuglov E.N., Ul’yanov A.A. et al. Application of autoplasma enriched with platelets in clinical practice. Biomeditsina, 2013, no. 4, pp. 46-59 (in Russ.).
24. Dolgov V.V., Svirin P.V. Laboratornaya diagnostika narusheniy gemostaza [Application of autoplasma enriched with platelets in clinical practice]. Moscow-Tver’: OOO “Izdatel’stvo “Triada”, 2005. 227 p.
25. Mazurov A.V. Fiziologiya i patologiya trombotsitov [Physiology and pathology of platelets]. Litterra, 2011. Pp. 10-56.
26. Shkvorchenko D.O., Zakharov V.D., Shpak A.A. et al. Our first experience in the use of platelet-rich blood plasma in the surgery of macular ruptures. Sovremennye tekhnologii v oftal’mologii, 2016, no. 1 (9), pp. 245-246 (in Russ.).